• Educational resources
  • Events
  • Expert Panel
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT
  • Contact us

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ItalyChange country/region
Dermatology

European Academy of Dermatology and Venereology (EADV) 2023 | Berlin

ADVENT Symposia brought global experts together to explore the latest advances in pediatric atopic dermatitis (AD), the shared and unique drivers of AD, prurigo nodularis (PN), and chronic spontaneous urticaria (CSU), and the pathology and patient management of PN.
Stephan Weidinger
Lawrence F. Eichenfield
Marlies de Graaf
MD, PhD
Stephan Weidinger +9 more
Past event
11October2023
Location
Messe Berlin Congress Center
Berlin Germany

Learning objectives

  • Describe the cumulative impact of the burdens of AD in children and the potential consequences later in life
  • Explore the potential of early control of type 2 inflammation to modify disease course
  • Review the evolving therapeutic landscape for children with AD, considering clinically relevant data supporting the use of advanced systemic therapies
  • Identify the shared and unique characteristics of AD, PN, and CSU including epidemiology, signs and symptoms, and comorbidities
  • Discuss how type 2 inflammation contributes to the clinical presentation of AD, PN, and CSU
  • Describe the role of type 2 inflammation in neuroimmune dysregulation and itch in AD, PN, and CSU
  • Recognize and elaborate on PN disease burden and classification
  • Describe the role of the molecules and processes that drive the complexities of PN disease
  • Review if emerging therapies can help address the heterogeneity of disease burden seen in PN patients

Description

  • New Horizons in Children With Atopic Dermatitis: Emerging Evidence in Disease Management
    In the ADVENT symposium, Drs. Stephan Weidinger, Lawrence Eichenfield, and Marlies de Graaf describe the impact of the burdens of AD in children and the potential consequences later in life. Additionally, they review the evolving therapeutic landscape for children with AD, considering clinically relevant data supporting the use of advanced systemic therapies.

     

  • Emerging Understanding of Chronic Itchy Skin Diseases: Shared and Unique Drivers in AD, PN, and CSU
    In the ADVENT symposium, Drs. Eric Simpson, Marta Ferrer, and Shawn Kwatra describe the mechanisms underlying the distinct clinical features and the common symptom of itch in AD, PN, and CSU.

     

  • Exploring Prurigo Nodularis: From Definition to Pathology and Patient Management
    Watch the ADVENT symposium, where Dr. Chih-Ho Hong hosts discussions by Drs. Brian Kim, Sarina Elmariah, and Sonja Ständer on many aspects of PN, including the way emerging treatments may help alleviate the burden of chronic diseases on patients.

Location

Messe Berlin Congress Center
Berlin Germany
Tags
biologicscaregiver burdencoexisting diseasescytokinesexpert insightsitchjak inhibitorsneuroimmune mechanismspediatricquality of lifesymposiumsymptomstype 2 inflammation
MAT-GLB-2305478 V2 11/2023

Speakers

Dermatology
MD, PhD

Stephan Weidinger

Professor and Chair for Dermatology at the Christian-Albrechts-University; Director of the Department of Dermatology and Allergy at the University Hospital Schleswig-Holstein, Campus Kiel, Germany

Dermatology
MD

Lawrence F. Eichenfield

Vice Chair of the Department of Dermatology | University of California San Diego (UCSD) School of Medicine; Chief of Pediatric and Adolescent Dermatology | Rady Children’s Hospital San Diego, California, United States

Dermatology
MD, PhD

Marlies de Graaf

Pediatric Dermatologist, University Medical Center of Utrecht, The Netherlands

Dermatology
MD

Eric Simpson

Professor of Dermatology, School of Medicine, Oregon Health & Science University, Portland, US

Allergy/Immunology
MD, PhD

Marta Ferrer

Head of the Department of Allergy at Navarra University Hospital, Pamplona, Spain

Dermatology
MD

Shawn Kwatra

Dr. Joseph W. Burnett Professor and Chair Department of Dermatology University of Maryland School of Medicine

Dermatology
MD

Chih-Ho Hong

Clinical Associate Professor in the Department of Dermatology and Skin Sciences, St. Paul’s Hospital, Vancouver, Canada

Dermatology
MD, PhD

Sarina Elmariah

Associate Professor and Dermatology Director at the UCSF Centre for Itch and Neurosensory Disorders at the University of California in San Francisco, California, US

Dermatology
MD

Brian Kim

Professor, Vice Chair of Research, and Site Chair of Mount Sinai West, Icahn School of Medicine, NY, US

Dermatology
MD

Sonja Ständer

Professor of Dermatology and Neurodermatology at the University of Münster; Head of the Interdisciplinary Center for Chronic Pruritus (KCP) at the University Hospital Münster, Germany